Efficacy and safety of Fufangkushen colon-coated capsule in the treatment of ulcerative colitis compared with mesalazine: A double-blinded and randomized study

Journal of Ethnopharmacology

Volumn 141, Issue 2, 2012, Pages 592-598

  Gong, Yang ^a   Zha, Qinglin ^b,c   Li, Li ^d   Liu, Yan ^d   Yang, Bo ^e   Liu, Liang ^c   Lu, Aiping ^d   Lin, Yifan ^a   Jiang, Miao ^d  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^b National Pharmaceutical Engineering Research Center   (China)

^c HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^d INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^e Beijing SL Pharmaceutical Co Ltd   (China)

Author keywords

Clinical trials; Fufangkushen colon coated capsule (FCC); Mesalamine; Traditional Chinese medicine; Ulcerative colitis

Indexed keywords

CHINESE DRUG; FUFANGKUSHEN; MESALAZINE; PLACEBO; UNCLASSIFIED DRUG;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; AGED; ANUS FISSURE; ANXIETY; ARTICLE; CHINESE MEDICINE; CLINICAL ASSESSMENT; CONJUNCTIVITIS; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG EFFICACY; DRUG SAFETY; ENTERITIS; FATIGUE; FEMALE; FEVER; GASTROINTESTINAL REFLUX; HEADACHE; HEAT; HEMORRHOID HEMORRHAGE; HERPES SIMPLEX; HUMAN; INDIGESTION; INSOMNIA; ISCHIALGIA; LEG EDEMA; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MENSTRUATION DISORDER; MULTICENTER STUDY; MYCOTICENTERITIS; NAUSEA; PAIN; PHARYNGITIS; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; RESPIRATORY DISTRESS; SCORING SYSTEM; SIDE EFFECT; TABLET; TREATMENT DURATION; TREATMENT RESPONSE; ULCER HEALING; ULCERATIVE COLITIS; UPPER RESPIRATORY TRACT INFECTION; URINE COLOR; VAGINA BLEEDING;

ADMINISTRATION, ORAL; ADULT; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS; CAPSULES; CHI-SQUARE DISTRIBUTION; CHINA; COLITIS, ULCERATIVE; DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INTESTINAL MUCOSA; MALE; MEDICINE, CHINESE TRADITIONAL; MESALAMINE; MIDDLE AGED; PLANTS, MEDICINAL; TABLETS, ENTERIC-COATED; TIME FACTORS; TREATMENT OUTCOME; WOUND HEALING;

EID: 84861197356     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2011.08.057     Document Type: Article

References (32)

1. T. Andus, A. Kocjan, M. Muser, A. Baranovsky, T.L. Mikhailova, T.D. Zvyagintseva, A.E. Dorofeyev, Y.S. Lozynskyy, I. Cascorbi, M. Stolte, M. Vieth, K. Dilger, R. Mohrbacher, and R. Greinwald Clinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis Inflammatory Bowel Diseases 16 2010 1947 1956
2. C.N. Bernstein, M. Fried, J.H. Krabshuis, H. Cohen, R. Eliakim, S. Fedail, R. Gearry, K.L. Goh, S. Hamid, A.G. Khan, A.W. LeMair, Malfertheiner, Q. Ouyang, J.F. Rey, A. Sood, F. Steinwurz, O.O. Thomsen, A. Thomson, and G. Watermeyer World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010 Inflammatory Bowel Diseases 16 2010 112 124
3. I. Bjarnason, and K. Middleton Effect of polymer coating on faecal recovery of ingested 5-amino salicylic acid in patients with ulcerative colitis Gut 29 1988 413
4. A. Bureau, J. Croteau, A. Tayeb, C. Merette, and A. Labbe Latent class model with familial dependence to address heterogeneity in complex diseases: adapting the approach to family-based association studies Genetic Epidemiology 35 2011 182 289
5. M. Buyse, S.L. George, S. Evans, N.L. Geller, J. Ranstam, B. Scherrer, E. Lesaffre, G. Murray, L. Edler, J. Hutton, T. Colton, P. Lachenbruch, and B.L. Verma The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials Statistics in Medicine 18 1999 3435 3451
6. M.J. Carter, A.J. Lobo, and S.P. Travis Guidelines for the management of inflammatory bowel disease in adults Gut 53 Suppl. 5 2004 V1 V16
7. T.M. Chang, X.M. Li, and X.D. Zhao Relationship between various Chinese medicine types and T-cell subsets in patients with ulcerative colitis Chinese Journal of Integrative Medicine 15 2009 220 223
8. W. Changhong, G. Wenyan, L. Yifan, C. Shanquan, Y. Zhuo, L. Yuping, G. Yang, and G. Yang Study of Fufangkushen colon-release capsule oil ulcerative colitis of endo-retention of damp heat type Modern Journal of Integrated Traditional Chinese and Western Medicine 18 2009 1453 1455 (in Chinese)
9. Z.S. Chen, C.M. Zhou, Y. Lu, Z.W. Nie, Q.L. Sun, Y.X. Wang, and Y. Chi Study on TCM syndrome-typing of chronic ulcerative colitis China National Journal of New Gastroenterology 2 1996 141 143
10. R.B. D'Agostino Sr., J.M. Massaro, and L.M. Sullivan Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics Statistics in Medicine 22 2003 169 186
11. F.C. Edwards, and S.C. Truelove The course and prognosis of ulcerative colitis. Iii. Complications Gut 5 1964 1 22
12. S.S. Ellenberg Biostatistics in clinical trials: Part 2. Determining sample sizes for clinical trials Oncology (Williston Park) 3 1989 39 46 discussion 48, 51
13. M.T. Fiorentini, M. Fracchia, G. Galatola, A. Barlotta, and M. de la Pierre Acute pancreatitis during oral 5-aminosalicylic acid therapy Digestive Diseases and Sciences 35 1990 1180 1182
14. G. Fiorino, W. Fries, S.A. De La Rue, A.C. Malesci, A. Repici, and S. Danese New drug delivery systems in inflammatory bowel disease: MMX and tailored delivery to the gut Current Medicinal Chemistry 17 2010 1851 1857
15. T.R. Fleming Current issues in non-inferiority trials Statistics in Medicine 27 2008 317 332
16. T. Fujimoto, J. Kato, J. Nasu, M. Kuriyama, H. Okada, H. Yamamoto, M. Mizuno, and Y. Shiratori Change of clinical characteristics of ulcerative colitis in Japan: analysis of 844 hospital-based patients from 1981 to 2000 European Journal of Gastroenterology and Hepatology 19 2007 229 235
17. K. Goh, and S.D. Xiao Inflammatory bowel disease: a survey of the epidemiology in Asia Journal of Digestive Diseases 10 2009 1 6
18. F. Hartmann, and J. Stein Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis Alimentary Pharmacology and Therapeutics 32 2010 368 376
19. K.L. Isaacs How rapidly should remission be achieved? Digestive Diseases 28 2010 548 555
20. H. Ito, M. Iida, T. Matsumoto, Y. Suzuki, H. Sasaki, T. Yoshida, Y. Takano, and T. Hibi Direct comparison of two different mesalamine formulations for the induction of remission in patients with ulcerative colitis: a double-blind, randomized study Inflammatory Bowel Diseases 16 2010 1567 1574
21. X.L. Jiang, and H.F. Cui An analysis of 10218 ulcerative colitis cases in China World Journal of Gastroenterology 8 2002 158 161
22. J.B. Kirsner, and R.G. Shorter Recent developments in nonspecific inflammatory bowel disease (second of two parts) New England Journal of Medicine 306 1982 837 848
23. A. Kornbluth, and D.B. Sachar Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee American Journal of Gastroenterology 99 2004 1371 1385
24. L. Langmead, and D.S. Rampton Review article: herbal treatment in gastrointestinal and liver disease - benefits and dangers Alimentary Pharmacology and Therapeutics 15 2001 1239 1252
25. L. Langmead, and D.S. Rampton Review article: complementary and alternative therapies for inflammatory bowel disease Alimentary Pharmacology and Therapeutics 23 2006 341 349
26. S.T. Lanza, and B.L. Rhoades Latent class analysis: an alternative perspective on subgroup analysis in prevention and treatment Prevention Science 2011 [Epub ahead of print]
27. P. Marteau, F. Nelet, M. Le Lu, and C. Devaux Adverse events in patients treated with 5-aminosalicyclic acid: 1993-1994 pharmacovigilance report for Pentasa in France Alimentary Pharmacology and Therapeutics 10 1996 949 956
28. K.W. Schroeder, W.J. Tremaine, and D.M. Ilstrup Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study New England Journal of Medicine 317 1987 1625 1629
29. B. Wang, S. Ren, W. Feng, Z. Zhong, and C. Qin Kui jie qing in the treatment of chronic non-specific ulcerative colitis Journal of Traditional Chinese Medicine 17 1997 10 13
30. Y. Wang, and Q. Ouyang Ulcerative colitis in China: retrospective analysis of 3100 hospitalized patients Journal of Gastroenterology and Hepatology 22 2007 1450 1455
31. B. Ye, H. Shen, Y. Lu, and Y.Q. Wang Clinical observations on 100 cases of ulcerative colitis treated with the method of clearing away heat, expelling dampness, promoting blood circulation and healing ulcer Journal of Traditional Chinese Medicine 30 2010 98 102
32. X.Y. Zheng New drug of TCM clinical research guidelines (Trial) [M] 2002 Medical Science and Technology Press Beijing pp. 3-8